Adam Feuerstein Does Not Think AMAG Pharma Will Be Sold Until After Phase 3 Data

by Allie Wickman, Benzinga Staff Writer

November 17, 2011 8:52 AM | 20 seconds read | Make a Comment

Adam Feuerstein, Senior Biotech Columnist at TheStreet.com,

that he believes AMAG Pharmaceuticals

AMAG

will eventually be sold, but not before the release of its phase 3 data in a couple months. AMAG Pharmaceuticals

that it has hired Jefferies & Company as a strategic advisor. Shares of AMAG Pharma are currently trading up over 4% .

Posted In: News Movers & Shakers FDA M&A General

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.